Clinical Trials Logo

Parkinson's Disease clinical trials

View clinical trials related to Parkinson's Disease.

Filter by:

NCT ID: NCT05773885 Recruiting - Parkinson's Disease Clinical Trials

Telerehabilitation in People With Parkinson's Disease

TEMPO
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Although TeleRehabilitation (TR) is widely accepted as an appropriate model for the provision of professional health services in the field of physiotherapy, with already established standards, guidelines and policies, there are still few studies in the literature on the use of TR as a rehabilitation tool in people with Parkinson's Disease (PD). Therefore, further studies on the efficacy of TR in the management of motor and non-motor symptoms of PD are needed. The study TEMPO aims at assessing the efficacy (in terms of autonomy in carrying out the activities of daily life) of a home TR program based on serious games in people with PD compared to conventional day-hospital treatment.

NCT ID: NCT05710588 Recruiting - Parkinson's Disease Clinical Trials

The Effectiveness of Motor-motor and Motor-cognitive Dual-task Training Interventions on Balance in People With Parkinson's Disease: a Feasibility Study

Start date: October 31, 2022
Phase: N/A
Study type: Interventional

This study aims to test the feasibility and acceptability of home-based motor-motor dual-task training and motor-cognitive dual-task training interventions, and balance-related outcome measures which may be used in an anticipated future randomized control trial intended to determine the superiority of these dual-task training interventions.

NCT ID: NCT05699460 Recruiting - Parkinson's Disease Clinical Trials

Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy

Start date: September 29, 2022
Phase:
Study type: Observational

The objective of this study is to describe disease progression in study participants diagnosed with early Parkinson's Disease or Multiple System Atrophy - Parkinsonian Type up to 18 months as delineated by clinical and biochemical parameters.

NCT ID: NCT05557864 Recruiting - Parkinson's Disease Clinical Trials

Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease

Start date: August 25, 2016
Phase: N/A
Study type: Interventional

This protocol will characterize the effects of deep brain stimulation (DBS) location (both adverse and beneficial) on motor signs in people with Parkinson's disease (PD). This information can be used to inform future DBS protocols to tailor stimulation to the specific needs of a patient. If targeted dorsal GP stimulation is shown to significantly improve motor features that are typically resistant to dopamine replacement therapy, these experiments will likely have major impact on clinical practice by providing a potential strategy to these medically intractable symptoms.

NCT ID: NCT05532982 Recruiting - Parkinson's Disease Clinical Trials

Parkinson's Disease in Asian Americans

Start date: October 15, 2022
Phase:
Study type: Observational

The ultimate goal of this project is to use the findings to develop culturally appropriate programs and resources that can be disseminated to key stakeholders to improve access to PD care and increase inclusivity in PD research for Asian Americans. This study will serve as a first step towards developing broader community and patient education programs and active outreach campaigns to increase PD-specific literacy among Asian Americans. The results from this study will elucidate the role that language barriers, cultural perceptions, family influence, and other predisposing, enabling, or need factors have on delaying care for PD among Asian Americans. It will also provide much needed insight on how to improve inclusion of Asian Americans in PD research studies.

NCT ID: NCT05523570 Recruiting - Parkinson's Disease Clinical Trials

A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension

Start date: August 22, 2022
Phase: Phase 1
Study type: Interventional

This is a non-randomized, dose-escalation first-in-human study to evaluate the safety, tolerability, PK, and PD of HNC364 following intramuscular administration of single ascending doses.

NCT ID: NCT05516732 Recruiting - Parkinson Disease Clinical Trials

Serotonin Release in Premotor and Motor PD

FOX3
Start date: July 1, 2022
Phase:
Study type: Observational

In this study, the investigators aim to provide a deeper understanding of Parkinson's disease and find a biomarker of Parkinson's disease. This is done using imaging scans called Positron Emission tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Imaging (MRI). The findings will provide a deeper understanding of the brain changes in Parkinson's disease. More importantly, this study will help with the discovery and development of new medications aiming to delay progression of Parkinson's disease symptoms

NCT ID: NCT05516719 Recruiting - Parkinson Disease Clinical Trials

Longitudinal Investigation of I2BS in PD

FOX_2
Start date: November 1, 2021
Phase:
Study type: Observational

In this study, the researchers aim to find a biomarker of PD. Using imaging scans called Positron Emission tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Imaging (MRI). The PET and SPECT scans use small amounts of radiation and specific compounds called tracers, to study chemical changes in the brain in a way not possible with any other procedure. The MRI uses magnetic fields to generate images of brain structure and function

NCT ID: NCT05483036 Recruiting - Parkinson's Disease Clinical Trials

Perception in Parkinson's Disease

Start date: September 1, 2022
Phase:
Study type: Observational

The investigators plan to examine the relation of perceptual variables-basic vision, unusual perceptual experiences(including but not limited to visual hallucinations)-to relevant functional variables such as cognition, mood, and alertness/sleepiness in an online sample of persons with Parkinson's disease (PwPD). It is hypothesized that unusual perceptual experiences will relate significantly to the selected variables. Participants do not need to experience visual hallucinations to be able to participate in this study. This is an observational study only, and not an interventional study.

NCT ID: NCT05471713 Recruiting - Parkinson's Disease Clinical Trials

MAPT Haploid H1b and the Damage of BBB in Dorsal Medulla Oblongata and Autonomic Dysfunction in PD

Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study mainly explored the relationship between the permeability of the blood-brain barrier in the dorsal medulla oblongata and autonomic dysfunction, and the relationship and mechanism of MAPT genotype on the permeability of the blood-brain barrier and the progression of autonomic dysfunction in PD patients.